Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group - Marty, M; Cognetti, F; Maraninchi, D (J Clin Oncol, 2005)
et al.